Taiwan pavilion to present 40+ technologies from 33 companies at the world’s largest biotechnology convention

SAN DIEGO, June 22, 2026 /PRNewswire/ — Taiwan is showcasing the strength of its biotechnology ecosystem at BIO International Convention 2026 in San Diego from June 22–25, bringing together 33 biotechnology companies and more than 40 innovative technologies as it seeks to deepen global partnerships, attract investment and reinforce its position as one of Asia’s leading biotechnology hubs.

Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and supported by Taiwan’s Ministry of Economic Affairs and other government agencies, the Taiwanese delegation will feature advancements spanning drug development, precision medicine, Contract Development and Manufacturing Organization (CDMO) services, biomanufacturing and digital health at the Taiwan Pavilion (Booth #2621).

Guided by the theme “Taiwan, Your Best Partner in Asia,” Taiwan is building on the strong engagement and partnerships forged at BIO 2025 and leveraging BIO 2026 as a launchpad to showcase its thriving innovation ecosystem, deepen strategic collaborations, and unlock new opportunities in licensing, co-development, manufacturing collaboration and investment.

Taiwan at BIO 2026: Key Events & Engagement Opportunities

• BIO Session (June 22,1:45-2:45 PM, Room 29AB)
  Bringing together experts from Taiwan, the United States, Singapore, Japan, and South Korea, the session will explore the future of chronic disease management and examine the healthcare economic value of Health Technology Assessment (HTA) from both technology and payer perspectives.
• Start-Up Stadium (June 22, 4:50-5:00 PM, Room 5B)
  Spotlight on Vacino Biotech, showcasing next-generation biotechnology innovations.
• Global Innovation Hub (June 23, 2:30-2:45 PM, Room 5A)
  Exploring Taiwan’s biotech ecosystem and partnership opportunities, fueled by a thriving startup landscape and dynamic capital markets that continue to achieve record highs in market valuation and fundraising.
• Taiwan Happy Hour Networking Reception (June 23, 4:00-5:00 PM, Taiwan Pavilion)
  An open networking session with more than 200 biotech leaders, investors, and global partners.

Taiwan’s Biotech Industry Surpasses NT$1 Trillion in Market Value Amid IPO Boom

Taiwan’s presence at BIO 2026 reflects the strength of its rapidly growing biotechnology sector. According to the 2025 Biotechnology Industry in Taiwan white paper, the industry generated a record NT$775.4 billion (US$25 billion) in revenue in 2024 and comprised 147 listed and over-the-counter biotech companies with a combined market value exceeding NT$1.47 trillion, underscoring Taiwan’s position as one of Asia’s leading biotechnology hubs.

“BIO 2026 offers an important opportunity for Taiwan’s biotech industry to demonstrate its manufacturing capabilities, connect with global partners and explore new avenues for collaboration,” said Michael Huang, Director of BPIPO. “We look forward to advancing healthcare innovation together with industry stakeholders worldwide.”

As BIO 2026 brings together biotechnology leaders, investors, and industry stakeholders from around the world, Taiwan’s participation provides an important platform for deepening international partnerships and accelerating cross-border collaboration. By showcasing its manufacturing capabilities, commercial-ready technologies and partnership opportunities, Taiwan aims to support the development of new technology partnerships, licensing agreements and clinical collaborations, while advancing its role in the global healthcare and life sciences ecosystem.

About BPIPO

The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) supports the growth and internationalization of Taiwan’s biomedical sector by fostering innovation, industry collaboration and global partnerships. For more information, please visit BPIPO’s website.

View the BravoTaiwan delegation list or discover more at www.bravotaiwan.cc

View original content to download multimedia:https://www.prnewswire.com/news-releases/taiwan-biotech-delegation-heads-to-bio-2026-to-advance-global-partnerships-and-innovation-302805308.html

SOURCE BPIPO